Handrails play a very important role in the aging of the family. Through a small handrail, create a safe and secure living environment for the elderly at home. When installing the handrail, pay attention to determine the installation height of the handrail according to the height of the elderly at home. The armrest is located at the crotch of the elderly. Generally speaking, it is about 80 to 85 cm from the ground. In order to provide safe and effective support for the elderly, different products need to be selected according to different installation conditions. Some families want to install handrails on non-load-bearing walls. We suggest that they install lining plates first, and then install handrails on the lining plates.
When selecting the material of the handrail, pay attention to the coordination with the furniture environment, create a warm atmosphere, avoid making it cold and hard, and do not give the elderly the illusion of "being a patient". For example, the wooden handrail in the video looks very warm and feels good. It is suitable for the elderly.
TRUTECH CO., LTD. is an enterprise specializing in the research, development, production and sales of professional OTC products.The main products include shower chairs, armrests, toilet racks and toilet armrests, bedside armrests, elderly chairs and sofas, crutches and walking aids, knee pads, waist supports and other equipment.
Grab Bar,Bathroom Grab Bars,Grab Bars For Shower,Shower Safety Bars TRUTECH CO., LTD. , https://www.trutechealth.com
Bendamustine hydrochloride for injection is officially listed in China
On May 30th, the medical network of Taiwei Medical Information Consulting (Shanghai) Co., Ltd. and Yourui Medical Technology jointly announced the launch of Cunda® (bendamustine hydrochloride for injection) products in China on May 26, 2019.
CSD® is suitable for inert B-cell non-Hodgkin's lymphoma (NHL) in the course of treatment with rituximab or rituximab regimen or after treatment. Teva successfully implemented clinical trials in China and obtained positive results in the China CSD® Phase 3 study in May 2016. Canda® was approved by the China National Drug Administration (NMPA) on December 17, 2018.